Product Images Sumatriptan

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Sumatriptan NDC 68788-6778 by Preferred Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1. Estimated Probability of Achieving Initial Headache Response Within 4 Hours of Treatment in Pooled Trials 1, 2, and 3a - sumatriptan fig1

Figure 1. Estimated Probability of Achieving Initial Headache Response Within 4 Hours of Treatment in Pooled Trials 1, 2, and 3a - sumatriptan fig1

Figure 2. The Estimated Probability of Patients Taking a Second Dose of Sumatriptan Tablets or Other Medication to Treat Migraine Over the 24 Hours Following the Initial Dose of Study Treatment in Pooled Trials 1, 2, and 3a - sumatriptan fig2

Figure 2. The Estimated Probability of Patients Taking a Second Dose of Sumatriptan Tablets or Other Medication to Treat Migraine Over the 24 Hours Following the Initial Dose of Study Treatment in Pooled Trials 1, 2, and 3a - sumatriptan fig2

Sumatriptan Succinate Tablets 100mg - sumatriptan fig5

Sumatriptan Succinate Tablets 100mg - sumatriptan fig5

This text appears to be a medication label for Sumatriptan Succinate Tablets, manufactured by Aurobindo Pharma Limited. Each tablet contains 100mg of Sumatriptan succinate. The label also contains cautionary information, however, the quality of is poor and the complete message is not readable.*

Chemical Structure - sumatriptan str

Chemical Structure - sumatriptan str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.